Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Revenue

Alnylam Pharmaceuticals had revenue of $1.46B in the quarter ending September 30, 2026, with 16.74% growth. This brings the company's total for the last twelve months to $5.01B, up 56.17% year-over-year. In the year 2025, Alnylam Pharmaceuticals had annual revenue of $3.71B with 65.19% growth. That makes Alnylam Pharmaceuticals the 2,636th largest company in the world by revenue and 769th in the United States.

• Revenue (ttm): $5.01B
• Revenue Growth: +56.17%
• P/S Ratio: 4.41
• Revenue / Employee: $2,005,297
• Employees: 2,500
• Market Cap: 22.11B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• AMVUTTRA 2.31B 62.3%
• Roche - Collaboration 394.88M 10.6%
• GIVLAARI 308.49M 8.3%
• OXLUMO 191.44M 5.2%
• Royalty 174.02M 4.7%
• ONPATTRO 172.79M 4.7%
• Regeneron Pharmaceuticals - Collaboration 113.96M 3.1%
• Other - Collaboration 44.53M 1.2%

By Geography

• United States 2.07B 69.2%
• Europe 651.09M 21.8%
• Rest of World 267.93M 9.0%

Fiscal year ended Dec 31, 2025 See the full Alnylam Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.71B	1.47B	65.19%
Dec 31, 2024	2.25B	419.95M	22.97%
Dec 31, 2023	1.83B	790.87M	76.23%
Dec 31, 2022	1.04B	193.13M	22.88%
Dec 31, 2021	844.29M	351.43M	71.31%
Dec 31, 2020	492.85M	273.10M	124.28%
Dec 31, 2019	219.75M	144.84M	193.36%
Dec 31, 2018	74.91M	-15.00M	-16.69%
Dec 31, 2017	89.91M	42.75M	90.66%
Dec 31, 2016	47.16M	6.06M	14.75%
Dec 31, 2015	41.10M	-9.46M	-18.72%
Dec 31, 2014	50.56M	3.39M	7.20%
Dec 31, 2013	47.17M	-19.56M	-29.31%
Dec 31, 2012	66.73M	-16.03M	-19.37%
Dec 31, 2011	82.76M	-17.28M	-17.28%
Dec 31, 2010	100.04M	-492.00K	-0.49%
Dec 31, 2009	100.53M	4.37M	4.54%
Dec 31, 2008	96.16M	45.27M	88.94%
Dec 31, 2007	50.90M	23.97M	89.00%
Dec 31, 2006	26.93M	21.21M	371.13%
Dec 31, 2005	5.72M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error